Central Bio Co., Ltd. Overview
Joongang Advanced Materials is a loss-making KOSDAQ micro-cap. It has two legacy operating businesses: telecommunications equipment, which made up 84% of Q2 2026 revenue, and PVC building materials and windows (16%). On top of these sit several strategic adjacencies, most of them still pre-revenue. Since 2023, the company's equity story has rested mainly on lithium hexafluorophosphate (LiPF6), a key electrolyte salt for lithium-ion batteries. It has pursued LiPF6 through a 50% joint venture, EDL, with Enchem, a Korean electrolyte maker, and through LiPF6 trading. The company sits inside a cross-shareholding group controlled by Enchem CEO Oh Jung-kang through Enchem and Kwangmu. Since 2025 it has also moved into defense and security, as the exclusive Korean value-added reseller for UK radar maker Blighter Surveillance Systems. Revenue (~KRW 20 bn) is small relative to its market value. The investment case therefore depends on executing these new businesses, on group governance, and on financing, not on current earnings.
Company self-description
Korean press descriptions drawn from company statements say that the company was founded in April 1999 and listed on KOSDAQ in 2001. At that time it operated telecommunications equipment, PVC products and building-materials manufacturing, and household goods distribution. In 2017 it absorbed affiliate Joongang Living Sash (중앙리빙샤시), which added PVC window-frame (sash) manufacturing (Asia Economy, January and October 2021). StockHub's summary of the company's business-report disclosures lists these activities: communication equipment and video/information display devices, PVC building materials, window and interior products, LED and lighting, distribution, and secondary-battery materials (StockHub, 2026).
From 2023, company communications repositioned the business around secondary-battery materials, specifically LiPF6 trading and production. The August 2023 rename to "Advanced Materials" was disclosed as reflecting business expansion centred on secondary batteries and an improved corporate image (Asia Economy, 12 September 2023). In 2026 the company presented itself in press materials as an advanced defense and security solutions company, centred on Blighter e-scan radars (Money Today, 2 September 2026).
Independent characterization
Taken together, the disclosures describe a holding-style micro-cap with a small legacy industrial base. Several themed initiatives have been layered onto that base over time:
-
construction and civil engineering (2021)
-
smart farms and real estate development (2021)
-
lithium salt (2023 onward)
-
information security via Initech (2025, reversed within two months)
-
rail/hydrogen tram (2025)
-
radar and anti-drone defense (2025–2026)
Few of these initiatives show up in reported revenue. The Q2 2026 revenue mix still consists entirely of the two legacy segments: telecommunications (84%) and PVC/building materials (16%) (Butler.works, Q2 2026).
Business model and revenue model
| Dimension | Characterization | Basis |
|---|---|---|
| Revenue model | Product sales (telecom equipment, PVC windows/building materials); trading/distribution margin (LiPF6 resale to Enchem, 2023–2024); equity-method exposure to EDL JV | Segment disclosure (Butler.works); LiPF6 contracts (Asia Economy, Aug–Nov 2023) |
| Service / subscription / licensing | No material service, subscription, or licensing revenue disclosed. Radar business includes local technical support and MRO, but revenue not disclosed | Money Today (Sep 2026) |
| Value chain position | Telecom: equipment manufacturer. PVC: manufacturer of window/building products. LiPF6: distributor today, prospective upstream producer via EDL. Radar: reseller/integrator (VAR) of imported hardware | Multiple |
| Customer types | B2B and B2G. Enchem was the disclosed LiPF6 counterparty. Defense, critical infrastructure, and public safety targeted for radar | Asia Economy (2023); Hankyung Money (Mar 2026) |
| End-markets | Telecommunications infrastructure; residential and commercial construction; lithium-ion battery electrolyte supply chain (US/EU via Enchem); defense and homeland security; urban rail (Daejeon Line 2 hydrogen tram) | Multiple |
Strategy
Stated strategic themes (paraphrased from company statements in press)
-
Secondary-battery materials vertical integration. Build an "Enchem – Joongang – EDL" vertical structure in which Joongang (through EDL) supplies LiPF6 to Enchem's electrolyte plants, reducing dependence on China (FN News, Jul 2024). Original targets: 10,000 t/yr by end-2024, 50,000 t/yr by end-2026, ~KRW 600 bn total investment (Asia Economy, Jul–Sep 2023).
-
Defense and security. Use the exclusive Blighter partnership plus domestic MRO and AI-based detection to address anti-drone and perimeter-security demand from the military, critical facilities, and infrastructure (Hankyung Money, Mar 2026; Money Today, Sep 2026).
-
Financial restructuring. Exit capital impairment, return to operating profit, and seek removal from KOSDAQ "investment caution" designation (Asia Economy, Nov 2023). Strengthen the capital base through rights issues (SmartToday, Apr 2025).
-
Governance stabilization. Consolidate control under Enchem (Dealsite, Dec 2025).
Initiatives in the last 24 months (Oct 2024 – Oct 2026)
| Initiative | Date | Description | Status | Source |
|---|---|---|---|---|
| Initech acquisition (security software) | Apr 2025 | 16.6% stake taken with Enchem; stated aim was new business and next-gen security technology | Reversed May 2025; stake sold | Hankyung; SmartToday |
| KRW 10 bn rights issue | Apr–May 2025 | Purpose: financial structure improvement and working capital | Payment due 15 May 2025 | SmartToday |
| Daejeon Line 2 hydrogen tram | c. Jul 2025 | Reported item with Maintrans covering 34 trainsets | — | eToday news list |
| Blighter exclusive VAR | By Feb 2026 | Exclusive Korean value-added reseller rights for Blighter e-scan radars | Active | Hankyung Money |
| KADIA MOU | 27 Feb 2026 | Joint R&D, market analysis, defense-business linkage for anti-drone systems | Active | Hankyung Money |
| K-SAFETY EXPO 2026 | 2–4 Sep 2026 | Radar and MRO capability showcase | Completed | Money Today |
| Share consolidation | Sep–Oct 2026 | Par-value consolidation | Completed 1 Oct 2026 | Butler.works |
| EDL construction restructuring | 3 Aug 2026 | IS Dongseo takes over remaining construction under a responsible-completion structure to support project finance | In progress | Dealsite (Aug 2026) |
Sustainability / ESG commitments
None publicly disclosed.
Cost programs
None publicly disclosed.
Medium-term guidance
| Target (when stated) | Stated goal | Outcome / latest |
|---|---|---|
| LiPF6 trading revenue (Aug 2023) | ~KRW 100 bn per year | Total company revenue FY2024 KRW 18.7 bn; FY2025 KRW 19.8 bn |
| EDL capacity (Jul 2023) | 20,000 t by end-2024; 50,000 t by end-2026 | Phase 1 of 10,000 t ~40% complete Aug 2026; commercial output targeted 2028 |
| EDL plant completion (Mar 2025) | Completion end-Dec 2025 | Slipped (see Aug 2026 status) |
| EDL plant completion (Dec 2025) | Q4 2026 completion | Superseded by 2028 commercial-production target (Aug 2026) |
| FY2023 full-year operating profit (Nov 2023) | "Very likely" | FY2023 operating income ~KRW 0.05 bn (marginally positive per aggregator) |
The company publishes no formal financial guidance. Historical informal targets have consistently missed:
Products & Services
Named product SKUs, specifications, and price lists for the telecom and PVC businesses are not published in any source reviewed. The catalog below records what is disclosed.
Telecommunications segment
| Product line | Description | Target customer | Launch / version | Pricing | Source |
|---|---|---|---|---|---|
| Wireless communication equipment | Manufacturing classified under KSIC 26429 (other wireless telecom equipment) | — | — | — | NTS registry |
| Video / information display devices | Listed in business-report summary | — | — | — | StockHub |
| LED & lighting | Listed in business-report summary | — | — | — | StockHub |
PVC products & building materials segment
| Product line | Description | Target customer | Launch / version | Pricing | Source |
|---|---|---|---|---|---|
| PVC window sash | Legacy Joongang Living Sash product line acquired via 2017 merger | Construction / housing | 2017 (via merger) | — | Asia Economy (2021) |
| Window & interior products | Listed in business-report summary | Construction / renovation | — | — | StockHub |
| Building materials | PVC-based building materials | Construction | — | — | StockHub |
Secondary-battery materials
| Product | Description | Customer | Status | Source |
|---|---|---|---|---|
| LiPF6 (lithium hexafluorophosphate), traded | Core electrolyte salt. Joongang resold product to Enchem ahead of in-house production | Enchem (incl. North American electrolyte supply) | Contracts Aug–Sep 2023; 2023 company guidance of ~KRW 100 bn/yr revenue not realized in reported figures | Asia Economy (2023) |
| LiPF6, produced (via EDL) | Saemangeum plant. Phase 1 10,000 t/yr; LiF (lithium fluoride) production also planned | Enchem group (Enchem America cited as key offtaker, NICE D&B "A" rating) | Under construction (~40%); commercial output targeted 2028 | Dealsite (Aug 2026) |
Defense & security
| Product / service | Description | Target customer | Status | Source |
|---|---|---|---|---|
| Blighter e-scan micro-Doppler radars | Ground-based radars made by Blighter Surveillance Systems (Cambridge, UK). They scan electronically instead of mechanically rotating an antenna. Optimized for small, low-altitude drones and intrusion detection. Blighter's B400 series is its established border-surveillance line | Military, critical national infrastructure, public safety | Exclusive Korean VAR; exhibited Sep 2026 | Hankyung Money (Mar 2026); Money Today (Sep 2026); Blighter PR (Oct 2025) |
| Local technical support & MRO | In-country maintenance, repair, and overhaul for Blighter radars | Same | Offered | Money Today (Sep 2026) |
| AI-based hazard auto-detection | Intelligent perimeter-security software being developed alongside radar supply | Same | Development | Hankyung Money (Mar 2026) |
Financial Narrative
Basis. Annual figures FY2021–FY2025 are DART-derived as presented by Butler.works. The aggregator does not state whether they are consolidated or standalone. ETFshopping reports FY2025 standalone revenue of KRW 19.2 bn against Butler's KRW 19.8 bn, which suggests Butler's figures are consolidated. Hankyung (1 Apr 2025) independently reports net losses of KRW 18.2 bn (FY2022), 48.4 bn (FY2023), and 76.8 bn (FY2024), consistent with Butler. Newstomato (2025) independently confirms FY2024 revenue of KRW 18.7 bn vs KRW 26.3 bn in FY2023.
Derived margins and growth (calculated from 6.1)
Revenue CAGR FY2021–FY2025: ~11.1% (KRW 13.0 bn → 19.8 bn). The CAGR hides a sharp spike in FY2022 followed by two years of contraction.
The company has paid no dividends; dividend yield is 0.00% (StockHub).
Commentary on income-statement trends
Revenue scale: Revenue has stayed between KRW 13 and 29 bn throughout. Revenue more than doubled in FY2022, then fell about 36% across FY2023–FY2024. The 2023 LiPF6 trading program was guided by the company at ~KRW 100 bn of annual revenue (Asia Economy and FN News, Aug 2023). It does not appear to have reached that scale: FY2023 revenue declined, and FY2024 fell a further 28.9%.
Operating losses: The company was essentially at operating breakeven only in FY2023 (KRW 0.05 bn). In Q3 2023 it reported standalone operating profit of KRW 1.07 bn on ~KRW 4.0 bn of quarterly revenue, together with quarterly net income of KRW 39.3 bn (Asia Economy, 13 Nov 2023). That large quarterly net income alongside a full-year net loss of KRW 48.4 bn indicates heavy non-operating items. The sources do not itemize them; likely candidates are derivative and CB valuation effects and investment gains and losses, but this is not confirmed. FY2024 operating loss widened to KRW 7.8 bn, then narrowed to KRW 4.6 bn in FY2025.
Below-the-line losses dominate: Net losses exceeded operating losses by KRW 12.6 bn (FY2021), 12.9 bn (FY2022), 48.4 bn (FY2023), 69.0 bn (FY2024), and 0.9 bn (FY2025). The FY2024 gap (KRW 69.0 bn) implies large impairments, valuation losses, or financial costs. The specific items are not itemized in the sources reviewed. The FY2025 net loss narrowed sharply to KRW 5.5 bn.
Balance sheet
Available indicators:
Implied book equity of about KRW 85–102 bn is several times the company's annual revenue. The balance sheet is therefore driven mainly by investments (EDL equity, loans, and financial assets), not by the operating businesses.
Cash flow
Operating cash flow, capex, free cash flow, and buybacks are not publicly verified for FY2021–FY2025. No dividends were paid.
The company has funded itself repeatedly through equity-linked instruments:
-
8th-series CB, KRW 8.8 bn (2020)
-
multiple third-party rights issues (2020–2021)
-
KRW 22 bn CB held by Enchem, converted July 2024
-
KRW 10 bn rights issue (April–May 2025)
This history points to persistent negative free cash flow funded externally. Operating losses in four of five years are consistent with that reading.
Inflections and drivers — summary
-
FY2022 revenue spike (+123.8%). The driver is not itemized. It coincides with the period after the 2021 change of control and the new business initiatives.
-
FY2023 near-breakeven operating result. Reflects Q3–Q4 2023 operating improvement and the start of LiPF6 trading revenue recognition from October 2023 (Asia Economy, Nov 2023).
-
FY2024 deterioration. Revenue fell 28.9%, operating loss widened to KRW 7.8 bn, and net loss reached KRW 76.8 bn. This coincided with the 2024 EV-demand slowdown, which the company itself cited as a headwind (Asia Economy, Jul 2025), and with LiPF6 price collapse (lithium prices hit a five-year low of CNY 58.9/kg in May 2025; Dealsite, Jul 2025).
-
FY2025 partial recovery. Revenue rose 5.9%; operating loss narrowed by about 41%; net loss shrank to KRW 5.5 bn. The Initech round trip (bought April 2025, sold May 2025 for KRW 26.3 bn) likely contributed a small realized gain. This is derived, not disclosed.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment (As Reported) Overview
| Segment (as reported) | Contents | Q2 2026 share of revenue (%) | Source |
|---|---|---|---|
Telecommunications business (통신사업) | Wireless communication equipment; video/information display devices (per business-report description) | 84 | Butler.works |
PVC products & building materials (PVC 제품 및 건축자재) | PVC window sash, window/interior products, building materials (legacy Joongang Living Sash) | 16 | Butler.works |
Unit / Initiative Details
| Unit / initiative | Structure | Status (latest verified) |
|---|---|---|
LiPF6 (lithium salt) trading | In-house distribution to Enchem | Contracts of ~KRW 11.3 bn disclosed Aug–Sep 2023 (Asia Economy reported KRW 16.5 bn cumulatively, Nov 2023). Not visible in Q2 2026 segment mix |
LiPF6 production | EDL Co., Ltd. JV (Joongang stake reported at 50% in Jul 2024) | Saemangeum phase 1 (10,000 t/yr) ~40% complete; commercial production targeted 2028 (Dealsite, Aug 2026). |
Defense & security (radar/anti-drone) | Exclusive Korean VAR for Blighter; in-house R&D centre | Marketing and partnerships stage; revenue not disclosed |
Rail / hydrogen tram | Reported involvement in Daejeon Line 2 hydrogen tram (34 trainsets) with Maintrans | — |
Income Statement
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (KRW Bn) | 13.0 | 29.1 | 26.3 | 18.7 | 19.8 |
Operating income (KRW Bn) | -4.6 | -5.4 | 0.05 | -7.8 | -4.6 |
Net income (KRW Bn) | -17.2 | -18.3 | -48.4 | -76.8 | -5.5 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating margin (%) | -35.4 | -18.6 | 0.2 | -41.7 | -23.2 |
Net margin (%) | -132.3 | -62.9 | -184.0 | -410.7 | -27.8 |
Margin Analysis (%) (FY2022–FY2025)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Revenue growth YoY (%) | 123.8 | -9.6 | -28.9 | 5.9 |
Financial Analysis
| Indicator | Value | Date | Source |
|---|---|---|---|
Price-to-book | 1.12–1.13x | Oct 2026 | Butler.works; StockHub |
Implied book equity (derived: market cap ÷ P/B) | ~KRW 85–102 bn | Oct 2026 | Derived; indicative only |
Capital impairment status | Exited partial capital impairment in Q3 2023 (standalone) via CB conversions and removal of refixing clauses | Q3 2023 | Asia Economy (Nov 2023) |
ROE (TTM) | -2.2% to -2.27% | Oct 2026 | Butler.works; StockHub |
Financial Analysis — ROE
| Ratio | Value | Basis |
|---|---|---|
ROE (TTM, Oct 2026) | -2.2% | Butler.works |
P/E | Not meaningful (loss-making) | Butler.works ("-") |
P/B | 1.12–1.13x | Butler.works; StockHub |
Valuation Snapshot
| Metric | Value | Date | Source |
|---|---|---|---|
Share price | KRW 8,640 | 13 Oct 2026 | StockHub |
Share price (alternative snapshot) | KRW 10,300 | Early Oct 2026 | Butler.works |
Market capitalization | KRW 96.0 bn – 114.4 bn | Oct 2026 | StockHub; Butler.works |
52-week range (as displayed, mixes pre- and post-consolidation prices) | KRW 805 – 10,740 | Oct 2026 | StockHub |
Pre-consolidation reference price | KRW 894 (52-week range then KRW 874–4,355) | Jul 2026 | StockHub (EN) |
P/E | Not meaningful (loss) | Oct 2026 | Butler.works |
P/B | 1.12–1.13x | Oct 2026 | Butler.works; StockHub |
Market cap / FY2025 revenue (derived) | ~4.8–5.8x | Oct 2026 | Derived |
Sector classification (StockHub) | Healthcare · Diagnostics & Research (legacy "Bio" classification; does not match current operations) | Oct 2026 | StockHub |
Capital Markets
| Item | Status |
|---|---|
Dividend history | No dividends paid; yield 0.00% (StockHub) |
Buyback authorizations | None found; treasury shares 0.20% (Butler.works) |
Moody's / S&P / Fitch | Not rated |
Domestic ratings (NICE, KIS, KR) | Affiliate customer Enchem America rated "A" by NICE D&B (Dealsite, Aug 2026) |
Equity-linked instruments history | 8th-series CB KRW 8.8 bn (2020; coupon 2.0%, YTM 5.0%, conversion price KRW 585); Enchem-held CB ~KRW 22 bn converted into 4,712,939 shares (Jul 2024). |
Analyst Conclusions
Management guidance
No formal financial guidance is published. Stated operational milestones:
-
EDL phase 1 commercial production in 2028 (Dealsite, Aug 2026)
-
Commercialization of Blighter-based anti-drone and perimeter-security solutions (Money Today, Sep 2026)
Consensus
No consensus exists (zero coverage).
Bull case
-
EDL delivers and Joongang's economics are preserved. If the Saemangeum phase 1 (10,000 t/yr) reaches commercial production in 2028, and Joongang retains a meaningful economic interest, the company gains exposure to an ex-China LiPF6 asset. That asset would have a policy-backed site and a creditworthy offtaker (Enchem America, NICE D&B "A"). Given the company's ~KRW 96–114 bn market value, this could be material.
-
Defense line converts to orders. Exclusive rights to proven Blighter e-scan radars, combined with the KADIA channel and domestic MRO, could produce B2G contracts. Blighter's repeat military orders abroad (Oct 2025 PR) suggest product credibility.
-
Loss trajectory improving and control consolidated. The operating loss narrowed about 41.5% in FY2025 and the net loss fell to KRW 5.5 bn. Consolidating control under Enchem (Dec 2025) may reduce the governance discount.
Bear case
-
Repeated over-promising. The ~KRW 100 bn/yr LiPF6 trading target and the 50,000 t/2026 capacity target both missed by wide margins. Without a change in execution, stated milestones deserve a heavy discount.
-
Value may sit outside the listed company. EDL was described in Aug 2026 as an "Enchem subsidiary". If Joongang's stake has been diluted below the 50% reported in 2024, Joongang shareholders may capture less of any EDL upside. Ownership of the most valuable assets inside the Oh Jung-kang group can be reshuffled.
-
Control and financing fragility. The Sep 2026 pledge filing, Enchem's KRW 571.1 bn FY2024 net loss, recurring equity issuance, and four loss-making years out of five point to continued dilution and control risk.
Catalysts and monitorables (next 12 months)
| Monitorable | Why it matters |
|---|---|
| Q3 2026 quarterly report (due mid-Nov 2026) | First post-consolidation results; segment mix; any defense or rail revenue |
| Details of 10 Sep 2026 supply contract | Size relative to ~KRW 20 bn annual revenue |
| Terms of Sep 2026 share pledge (pledgor, amount, triggers) | Control-change risk |
| Joongang's current equity stake in EDL | Determines exposure to the LiPF6 thesis |
| EDL project-finance close and construction progress beyond ~40% | Feasibility of 2028 start |
| First Blighter radar order announcement | Validation of the defense pivot |
| Maintrans / Daejeon hydrogen tram contract specifics | Whether the rail exposure is real revenue |
| KOSDAQ caution-designation status and any new equity issuance | Listing and dilution risk |
| FY2026 annual report (Mar 2027) | Full-year trend; auditor opinion |
Analyst verdict
Joongang Advanced Materials, formerly Central Bio, is best understood as an option-laden shell inside the Enchem/Oh Jung-kang corporate group, not as an operating company that can be valued on its earnings. Its reported business is small: about KRW 20 bn of revenue in FY2025, nearly all from telecom equipment and PVC building materials, with operating losses in four of the past five years. Yet the market values it at roughly KRW 96–114 bn, about five times revenue and slightly above book value.
Each narrative has merit at the industry level. Ex-China LiPF6 supply is genuinely scarce, drone threats are real, and Korea is building hydrogen tram lines. The company's record of turning these narratives into revenue is weak, however. The LiPF6 trading target of about KRW 100 bn a year never appeared in reported results. EDL's capacity and timeline have been cut and pushed back from 50,000 tonnes by 2026 to a 10,000-tonne first phase producing commercially in 2028. The Initech investment was reversed within two months. Governance adds further discount: control sits within a cross-shareholding network, a September 2026 share-pledge filing flags possible control change, and the anchor shareholder Enchem itself reported very large losses in 2024.
The narrowing FY2025 loss, the December 2025 control consolidation, and the October 2026 share consolidation do mark a cleaner starting point. In our view the equity remains highly speculative. Re-rating would require verifiable evidence: a confirmed Joongang economic stake in EDL, project-finance close for the Saemangeum plant, and named, sized defense or rail contracts.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Prior roles / notes | Compensation | Source |
|---|---|---|---|---|
Kim Young-shin (김영신) | Representative director (CEO) | — | Not publicly disclosed (individual pay disclosure applies only above KRW 500 m) | NTS registry; ETFshopping |
Jung Jun-hwa (정준화) | Head of R&D Centre | Signed KADIA MOU, Feb 2026 | — | Hankyung Money (Mar 2026) |
Oh Jung-kang (오정강) | Not an officer of Joongang per sources reviewed. CEO of Enchem and of EDL; described as controlling shareholder of both Enchem and Joongang, and owner of Kwangmu, Sangji Construction, Atlas 8000 | Received the Order of Industrial Service Merit (Silver Tower) for electrolyte localization (eToday) | — | Hankyung (Apr 2025); Asia Economy (Aug 2023); eToday |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change | Source |
|---|---|---|
21 Jan 2021 | Lee Eung-geun (CEO), Kim Byung-gak (VP), Won Dae-sung (managing director), all former Sambu Construction executives, elected inside directors, among five new inside directors | Asia Economy (21 Jan 2021) |
Major Shareholders
| Holder | Stake (%) | Date / basis | Source |
|---|---|---|---|
Kwangmu Co., Ltd. (KOSDAQ: 029480), largest shareholder of record | 14.46 | FY2025 business report | ETFshopping |
Enchem Co., Ltd. (KOSDAQ: 348370), related party | 14.53 | After 23 Dec 2025 purchase of Atlas 8000's 5.27% stake | Dealsite (29 Dec 2025) |
Largest shareholder incl. related parties | 28.99 | FY2025 business report | ETFshopping |
Minority shareholders (56,184 holders) | 65.63 | FY2025 business report | ETFshopping |
Treasury shares | 0.20 | Oct 2026 | Butler.works |
Avenir Partners / Sun Dae-in / Kim Tae-hyun | — | Apr 2025 | SmartToday |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Positioning vs. Joongang |
|---|---|---|
PVC windows & building materials (Korea) | LX Hausys | Market leader; far larger scale and brand |
PVC windows & building materials | KCC Glass (Homecc) | Large integrated glass and windows player |
PVC windows & building materials | Hyundai L&C | Large materials affiliate of Hyundai Department Store group |
PVC windows & building materials | Eagon Windows & Doors | Premium window/door specialist |
LiPF6 / electrolyte salts (Korea) | Chunbo | Listed Korean electrolyte-salt maker (LiFSI, LiPF6-related) |
LiPF6 / electrolyte salts (Korea) | Foosung | Korean LiPF6 producer with operating capacity |
LiPF6 / electrolyte salts (global) | Tinci Materials (China) | Leading Chinese electrolyte/LiPF6 producer |
LiPF6 / electrolyte salts (global) | Do-Fluoride (DFD) (China) | Major Chinese LiPF6 producer |
LiPF6 / electrolyte salts (global) | Stella Chemifa; Kanto Denka (Japan) | Established non-Chinese LiPF6 producers |
Radar / anti-drone (Korea) | LIG Nex1; Hanwha Systems | Large prime defense contractors with in-house radar |
Radar / anti-drone (global) | Echodyne (US); Robin Radar (Netherlands) | Competing compact e-scan / drone-detection radar vendors |
Telecom equipment | Not identified with confidence (product lines not disclosed) | — |
Key Competitors
| Company | FY2024 revenue (KRW Bn) | Note | Source |
|---|---|---|---|
Joongang Advanced Materials | 18.7 | FY2025: 19.8 | Butler.works |
Enchem (related party, electrolyte) | 365.0 | FY2024 net loss KRW 571.1 bn | Hankyung (Apr 2025) |
Recent Developments
Twenty-one material developments could be verified in this window.



